CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Ken Poss

June 22, 2020 | Development

An interview with Ken Poss

Ken Poss recently joined the Development team as associate editor, focusing on the field of regenerative biology. Development interviewed him to find out more about his career, research, and why he decided to get involved with the journal.  

Yarui Diao

June 19, 2020

Cancer: The wound that never heals

Yarui Diao is trying to shed more light on rhabdomyosarcoma in an effort to come up with better treatment options.

April 21, 2020 | Duke Research Blog

Asokan, Gersbach research highlighted by Vice President of Research

Dr. Carin reflects on how Duke's fundamental research can turn viruses into marvels.